Akebia Therapeutics
AKBA
#7042
Rank
C$0.55 B
Marketcap
$2.54
Share price
1.68%
Change (1 day)
87.62%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -C$54.99 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are C$0.17 Billion. In 2023 the company made an earning of -C$72.61 Million, an increase over its 2022 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$54.99 Million-24.27%
2023 -C$72.61 Million-45.12%
2022 -C$0.14 Billion-66.55%
2021 -C$0.4 Billion-26.24%
2020 -C$0.54 Billion33.94%
2019 -C$0.41 Billion66.52%
2018 -C$0.25 Billion123.53%
2017 -C$0.11 Billion-43.34%
2016 -C$0.19 Billion123.58%
2015 -C$84.9 Million63.95%
2014 -C$51.79 Million181.24%
2013 -C$18.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.54 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.80 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$25.72 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.25 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA